Callan was founded as an employee-owned investment consulting firm in 1973. Ever since, we have empowered institutional investors with creative, customized investment solutions backed by proprietary research, exclusive data, and ongoing education. Today, Callan advises on more than $3 trillion in total fund sponsor assets, which makes it among the largest independently owned investment consulting firms in the U.S. Callan uses a client-focused consulting model to serve pension and defined contribution plan sponsors, endowments, foundations, independent investment advisers, investment managers, and other asset owners. Headquartered in San Francisco, Callan also has offices in Chicago, Denver, Atlanta, Summit, NJ, and Portland, OR. Note: Please do not share any personal information, investment advice, stock tips, or testimonials about Callan’s people or services on our LinkedIn, Twitter, or Facebook pages. Callan is not responsible for and does not endorse any content, advertising, products, advice, opinions, recommendations or other materials from followers or third parties. Any comments posted by LinkedIn or Twitter users are those of the persons submitting them and do not represent Callan. If Callan interacts with other social media content (e.g., by "liking"​ or “retweeting” information, sharing links, etc.), it is not an endorsement of the individual or organization.

One of the nation's premier plaintiffs'​ law firms, Lieff Cabraser Heimann & Bernstein, LLP, is a 125-plus attorney law firm with offices in San Francisco, New York, Nashville, and Munich. We are among the largest law firms in the United States that only represent plaintiffs. A strong, principled sense of social responsibility drives us. We are committed to achieving justice for consumers, employees, patients, investors, and small business owners; promoting safer products and fair competition; protecting our environment; assisting whistleblowers stop fraud in government contracts and services; preserving our right to privacy, safeguarding the rights of inventors; and remedying violations of civil and human rights. Since our founding fifty-one years ago, Lieff Cabraser has participated in many of the most important individual and class action lawsuits in the United States, helping recover over $124 billion in verdicts and settlements for our clients. Disclaimer/Attorney Advertising Notice This page may be considered advertisement in some jurisdictions. The determination of the need for legal services and the choice of a lawyer are extremely important decisions and should not be based solely upon advertisements or self-proclaimed expertise. Prior results do not guarantee a similar outcome.

Shartsis Friese LLP is one of San Francisco’s leading law firms. Shartsis Friese is known for its trial and litigation capabilities and is regularly called upon to handle some of the most exciting cases in state and federal court in California. The firm also serves as outside general counsel to some of the region’s leading mid-cap companies, while maintaining premier practices in areas such as hedge funds and investment advisors, securities enforcement defense, real estate, intellectual property, insurance coverage, family wealth planning, patent prosecution, venture capital, and trusts & estates litigation.

Keker, Van Nest & Peters is a trial-practice litigation firm located in San Francisco. For more than 40 years, we have devoted our practice exclusively to complex civil and criminal litigation. Our record of success at trial, motions practice, appeals and alternative dispute resolution has earned the firm its reputation for solving bet-the-company intellectual property, commercial and white-collar crime disputes. We litigate and try cases in state and federal courts throughout California and the nation.

Theravance Biopharma aims to transform the treatment of specialty respiratory and neurologic diseases by delivering Medicines that Make a Difference® in patients’ and caregivers’ lives. In pursuit of our purpose, Theravance Biopharma leverages decades of expertise, which has led to the development of FDA-approved YUPELRI® (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD). Our pipeline of internally discovered programs is targeted to address significant unmet patient needs. As a spin-off of Theravance, Inc., Theravance Biopharma, Inc. was founded in 2014 and has offices in South San Francisco, and Dublin, Ireland. We are a place for collaborators and creative problem-solvers – people who thrive on applying insight and innovation to discovering novel medicines. We invite you to explore our job opportunities and learn more about what Theravance Biopharma has to offer www.theravance.com/join-our-team/our-culture-values. You can also connect with us on Twitter at @TheravanceBio. Please visit www.theravance.com/social-media-guidelines for more information on how to engage with Theravance Biopharma on social media.

Accel is a leading venture capital firm that invests in people and their companies from the earliest days through all phases of private company growth. Atlassian, Braintree, Cloudera, CrowdStrike, DJI, Dropbox, Dropcam, Etsy, Facebook, Flipkart, FreshWorks, Jet, Qualtrics, Slack, Spotify, Supercell, UiPath and Vox Media are among the companies the firm has backed over the past 40 years. For more, visit www.accel.com or www.twitter.com/accel.

Located in the heart of Silicon Valley, Baidu USA is one of the R&D centers of Baidu, China’s largest search engine provider. Baidu USA’s team of elite, world-class researchers and engineers devote their time to tackling the most challenging, change-the-world projects in AI and related fields. Baidu USA is comprised of four groups: Baidu Research US, Intelligent Driving Group US, Baidu USDC and Smart Living Group US. At Baidu USA, we act with the nimbleness of a startup, but as a global company, have access to immense computing resources and data. This makes Baidu USA the best place for those working in AI to see their work developed and potentially deployed to hundreds of millions of users. The name Baidu was inspired by a poem written more than 800 years ago during China's Song Dynasty. Baidu, whose literal meaning is “hundreds of times,” represents a persistent search for the ideal.

Rigel Pharmaceuticals, Inc., is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients hematologic disorders, cancer and rare immune diseases.

The SETI Institute is a non-profit research organization, located in the Silicon Valley close to the NASA Ames Research Center. Our mission is to lead humanity's quest to understand the origins and prevalence of life and intelligence in the universe and share that knowledge with the world. The SETI Institute is committed to respecting values of diversity, equity, inclusion, and access (DEIA) and creating and maintaining a positive and nurturing work environment that promotes mutual respect, trust, fairness, and objectivity. We strive to provide professional and personal growth to every individual regardless of race, color, religion, ethnicity, gender, age, sexual orientation, disability, or national origin. As a group of talented scientists, engineers, educators, and professionals, it is our belief that a diverse, equitable, inclusive, and accessible workplace is critical to accomplishing the Institute’s mission, and ensuring that we follow our values and principles.

For over 40 years, DES Architects + Engineers has created working, learning, and healing environments. As a multi-disciplinary design firm, DES provides creative, sustainable solutions to meet the needs of development, science and tech, healthcare, and education clients. DES values collaboration to achieve design excellence, focusing on each client’s unique vision, culture, and values. DES offers an integrated project approach that leads to increased accuracy, quicker project delivery, and a better use of valuable resources. With offices in Redwood City and San Francisco, DES provides seven in-house services: Architecture, Interior Design, Structural Engineering, Civil Engineering, Landscape Architecture, Visual Communications and Green Building Consulting.

Codexis is a leading enzyme engineering company leveraging its proprietary CodeEvolver® platform to discover, develop and enhance novel, high-performance enzymes and other classes of proteins. Codexis enzymes solve for real-world challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' unique enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications.